Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

Figure 7

Comparison of % drug release of Nebivolol immediate release tablets (NBL1–NBL9).